Margaret Moran

ORCID: 0000-0002-9342-865X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Palliative Care and End-of-Life Issues
  • Diabetes Management and Education
  • Obesity and Health Practices
  • Chronic Disease Management Strategies
  • Diabetes Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Patient Dignity and Privacy
  • Pharmacology and Obesity Treatment
  • Obesity, Physical Activity, Diet
  • Economic and Financial Impacts of Cancer
  • Pharmaceutical Practices and Patient Outcomes
  • Workplace Health and Well-being
  • Medication Adherence and Compliance
  • Primary Care and Health Outcomes
  • Cancer survivorship and care
  • Physical Activity and Health
  • Nursing education and management
  • Healthcare Policy and Management
  • Nutritional Studies and Diet
  • Health disparities and outcomes
  • Dementia and Cognitive Impairment Research
  • Diabetes Management and Research
  • Advances in Oncology and Radiotherapy
  • Disaster Response and Management
  • Childhood Cancer Survivors' Quality of Life

Northwestern University
2016-2020

Midwest Orthopaedic Research Foundation
2018

Institute for Community Health
2017

University of Chicago Medical Center
2016

Erie Family Health Center
2016

Edinburgh Napier University
2016

<h3>Importance</h3> Understanding cardiovascular outcomes of initiating second-line antidiabetic medications (ADMs) may help inform treatment decisions after metformin alone is not sufficient or tolerated. To date, no studies have compared the effects all major ADMs during this early decision point in pharmacologic management type 2 diabetes. <h3>Objective</h3> examine association ADM classes with adverse events. <h3>Design, Setting, and Participants</h3> Retrospective cohort study among 132...

10.1001/jamanetworkopen.2018.6125 article EN cc-by-nc-nd JAMA Network Open 2018-12-21

Purpose The purpose of this study was to explore how adults with prediabetes perceive their risk developing diabetes and examine preferences for evidence-based treatment options prevent diabetes. Methods A qualitative conducted in 2 large Midwest primary care practices, involving in-depth semistructured interviews 35 adult patients prediabetes. Results This ethnically diverse (77% nonwhite) sample middle-aged exhibited multiple factors. Knowledge gaps about its medical management were...

10.1177/0145721716666678 article EN The Diabetes Educator 2016-09-13

Offering patient-centered care to prevent diabetes will require collaborative decision-making between patients with prediabetes and their health providers. From the perspective of primary providers, detection should be targeted who are most likely benefit from diagnosis treatment. Improving access lifestyle intervention programs educating providers about evidence-based treatments for how effectively discuss treatment options may improve both providers' patients' engagement in prevention.

10.2337/cd17-0049 article EN cc-by-nc-nd Clinical Diabetes 2017-11-30

Early palliative care referral for patients with advanced cancer has demonstrable benefits but is underutilized. We sought to characterize medical oncologists' perceptions about in their clinical practices.We conducted 4 focus groups a national sample of oncologists elicit perspectives the optimal timing and barriers cancer. used qualitative content analysis uncover themes related early integration into standard oncologic practice.Study participants readily acknowledged evidence supporting...

10.21037/apm-20-270 article EN Annals of Palliative Medicine 2020-08-13

Objectives: Examine the social influence of adult children on cardiovascular-related health behaviors older South Asian (SA) immigrants to inform lifestyle interventions.Design: This mixed-methods study used data from an ancillary networks (2014–2018) in Mediators Atherosclerosis Asians Living America cohort. Phase 1 was a quantitative analysis self-reported diet and physical activity among SA adults (n = 448, mean age 58 years, SD 8.4) who named at least one child their network. The...

10.1080/13557858.2020.1734779 article EN Ethnicity and Health 2020-03-02

Past research provides insufficient evidence to inform second-line diabetes medication prescribing when metformin is no longer sufficient. We evaluated patient, prescriber, and health plan characteristics associated with selection of medications in the USA.We used a multiple case-comparison study design identify probability starting each six alternatives within 77 744 adults enrolled commercial or Medicare Advantage plans from 2011 2015. National administrative data were provided by large...

10.1136/bmjdrc-2017-000421 article EN cc-by-nc BMJ Open Diabetes Research & Care 2017-08-01

Early identification of cognitive impairment (CI), including Alzheimer's disease and related dementias (ADRD), is a top public health priority. Yet, CI/ADRD often undetected underdiagnosed within primary care settings, in disparate populations. The MyCog paradigm an iPad-based, self-administered, validated assessment based on the National Institutes Health (NIH) Toolbox Cognition Battery coupled with clinician decision-support tools that specifically tailored for detection diverse, settings....

10.1136/bmjopen-2023-080101 article EN cc-by-nc BMJ Open 2023-10-01

e22191 Background: Early integration of palliative care for patients with advanced cancer has demonstrable benefits but is underutilized. We sought to characterize medical oncologists’ perspectives on and identify barriers its early integration. Methods: A national sample oncologists (N = 31) was recruited participate in four focus groups. The groups were audio recorded, transcribed verbatim, the transcripts independently reviewed coded by investigators from diverse healthcare backgrounds...

10.1200/jco.2018.36.15_suppl.e22191 article EN Journal of Clinical Oncology 2018-05-20

This retrospective cohort study compared the effectiveness of six antidiabetic medication (ADM) classes on major adverse cardiovascular events. Using nationwide U.S. administrative claims data from 2011-2015, we studied 132,737 insured adults with type 2 diabetes who started one ADM after taking metformin alone or no prior ADM. The key exposure was new class, which filled ≥2 times. composite primary outcome included hospitalization for following conditions: heart failure, stroke, ischemic...

10.2337/db18-1125-p article EN Diabetes 2018-06-22
Coming Soon ...